AOCOPM 2023 Midyear Educational Conference-259668

259668 - Article 15

Pdf Summary

The AOCOPM 2023 Midyear Educational Conference focused on the intersection of correctional medicine and reducing recidivism through addiction treatment. Key issues addressed included the significantly higher rates of serious mental illness and substance use disorders in incarcerated populations compared to the general community—17% vs. 5% for mental illness, and 68% vs. 8.5% for substance use disorders. The conference underscored the potential benefits of effectively treating substance use disorder (SUD) in reducing incarceration and improving health outcomes. <br /><br />An emphasis was placed on evidence-based treatment modalities for opioid use disorder, primarily buprenorphine, methadone, and naltrexone, within correctional settings. Painful withdrawal can be mitigated using these medications, which have been shown to decrease not only overdose deaths but also criminal behavior. Methods for managing withdrawal, such as the Clinical Opiate Withdrawal Scale and Withdrawal Opioid Withdrawal Scale, were discussed as essential tools for initiating treatment. Real-world examples, like the Salt Lake City Jail's program that significantly reduced recidivism rates amongst enrolled inmates, demonstrated the effectiveness of medication-assisted treatment (MAT).<br /><br />The ADA’s role in mandating treatment for addiction as a disability was highlighted, noting that denial of treatment could lead to legal challenges against correctional facilities. The conference advocated for the inclusion of MOUD (Medication for Opioid Use Disorder) across correctional settings, accelerated by Department of Justice requirements. Additionally, the removal of the DATA Waiver for prescribing buprenorphine helps facilitate broader access to treatment.<br /><br />Transition care to the community was emphasized to prevent overdose deaths post-release, with recommendations for structured support, including job placement, ongoing psychiatric care, and immediate integration into community treatment programs. This comprehensive approach aims to integrate former inmates successfully and reduce rates of recidivism and overdose.

Keywords

AOCOPM 2023

correctional medicine

recidivism

addiction treatment

substance use disorder

opioid use disorder

medication-assisted treatment

buprenorphine

Department of Justice

community transition care